This is an administrative multianalyte assay with algorithmic analysis (MAAA) code represented by a proprietary name in the CPT® MAAA code appendix, meaning that the code applies to only one unique lab test made by a specific manufacturer or performed by a specific lab. Report 0020M only for Epignostix CNS Tumor Methylation Classifier from Heidelberg Epignostix GmbH. The test analyzes 30,000 DNA methylation loci in tumor tissue from the central nervous system (CNS) using a methylation array to detect specific patterns of DNA methylation. The purpose is to compare these patterns against reference tumor subclasses to aid in diagnosing the specific type of CNS tumor. Results are reported as the probability of the sample matching a known reference tumor subclass, facilitating targeted therapeutic strategies.
For clinical responsibility, terminology, tips and additional info
start codify free trial.